INFLAMMATION ET CEC
04/2008
(1) Asberg AE, Mollnes TE, Videm V:
Complement Activation by Neutrophil Granulocytes.
Scand.J.Immunol. 2008; .:
(2) Atkinson VP, Soeding P, Horne G, Tatoulis J: Cold
agglutinins in cardiac surgery: management of myocardial protection and
cardiopulmonary bypass. Ann.Thorac.Surg. 2008; 85: 310-1
(3) Bert C, De Buck F, Sergeant P, Van Hemelrijck J, Kasran A,
Van D, V, Ceuppens J, Meyns B, Delforge M, Wouters P:
Aprotinin reduces cardiac troponin I release and inhibits apoptosis of
polymorphonuclear cells during off-pump coronary artery bypass surgery.
J.Cardiothorac.Vasc.Anesth. 2008; 22: 16-22
(4) Bierbach B, Meier M, Kasper-Konig W, Heimann A, Alessandri
B, Horstick G, Oelert H, Kempski O: Emboli formation rather
than inflammatory mediators are responsible for increased cerebral water content
after conventional and assisted beating-heart myocardial revascularization in a
porcine model. Stroke. 2008; 39: 213-9
(5) Boldt J, Brosch C, Rohm K, Papsdorf M, Mengistu A:
Comparison of the effects of gelatin and a modern
hydroxyethyl starch solution on renal function and inflammatory response in
elderly cardiac surgery patients. Br.J.Anaesth. 2008; .:
(6) Caso G, Vosswinkel JA, Garlick PJ, Barry MK, Bilfinger TV,
McNurlan MA: Altered protein metabolism following coronary
artery bypass graft (CABG) surgery. Clin.Sci.(Lond). 2008; 114: 339-46
(7) de Lange F, Yoshitani K, Proia AD, Mackensen GB, Grocott
HP: Perfluorocarbon administration during cardiopulmonary
bypass in rats: an inflammatory link to adverse outcome? Anesth.Analg.
2008; 106: 24-31, table
(8) Eggum R, Ueland T, Mollnes TE, Videm V, Aukrust P, Fiane
AE, Lindberg HL: Effect of perfusion temperature on the
inflammatory response during pediatric cardiac surgery. Ann.Thorac.Surg.
2008; 85: 611-7
(9) Florio P, Abella R, Marinoni E, Di Iorio R, Letizia C, Meli
M, de la TT, Petraglia F, Cazzaniga A, Giamberti A, Frigiola A, Gazzolo D:
Adrenomedullin blood concentrations in infants subjected to
cardiopulmonary bypass: correlation with monitoring parameters and prediction of
poor neurological outcome. Clin.Chem. 2008; 54: 202-6
(10) Kilickan L, Yumuk Z, Bayindir O: The
effect of combined preinduction thoracic epidural anaesthesia and glucocorticoid
administration on perioperative interleukin-10 levels and hyperglycemia. A
randomized controlled trial. J.Cardiovasc.Surg.(Torino). 2008; 49: 87-93
(11) Kolackova M, Kudlova M, Kunes P, Lonsky V, Mandak J,
Andrys C, Jankovicova K, Krejsek J: Early expression of
FcgammaRI (CD64) on monocytes of cardiac surgical patients and higher density of
monocyte anti-inflammatory scavenger CD163 receptor in "on-pump" patients.
Mediators.Inflamm. 2008; 2008:235461.: 235461
(12) Lagan AL, Melley DD, Evans TW, Quinlan GJ:
Pathogenesis of the systemic inflammatory syndrome and
acute lung injury: role of iron mobilization and decompartmentalization.
Am.J.Physiol Lung Cell Mol.Physiol. 2008; 294: L161-L174
(13) Loukanov T, Arnold R, Gross J, Sebening C, Klimpel H,
Eichhorn J, Hoss K, Ulmer HE, Kark M, Gorenflo M:
Endothelin-1 and asymmetric dimethylarginine in children with left-to-right
shunt after intracardiac repair. Clin.Res.Cardiol. 2008; .:
(14) Lull ME, Carkaci-Salli N, Freeman WM, Myers JL, Midgley
FM, Thomas NJ, Kimatian SJ, Vrana KE, Undar A: Plasma
biomarkers in pediatric patients undergoing cardiopulmonary bypass.
Pediatr.Res. 2008; .:
(15) Marcheix B, Carrier M, Martel C, Cossette M, Pellerin M,
Bouchard D, Perrault LP: Effect of pericardial blood
processing on postoperative inflammation and the complement pathways.
Ann.Thorac.Surg. 2008; 85: 530-5
(16) Ng CS, Arifi AA, Wan S, Ho AM, Wan IY, Wong EM, Yim AP:
Ventilation during cardiopulmonary bypass: impact on
cytokine response and cardiopulmonary function. Ann.Thorac.Surg. 2008;
85: 154-62
(17) Roldan V, Marin F, Lip GY: Letter by
Roldan et al regarding article, "Plasminogen activator inhibitor-1 as a
predictor of postoperative atrial fibrillation after cardiopulmonary bypass".
Circulation. 2008; 117: e169
(18) Szerafin T, Hoetzenecker K, Hacker S, Horvath A, Pollreisz
A, Arpad P, Mangold A, Wliszczak T, Dworschak M, Seitelberger R, Wolner E,
Ankersmit HJ: Heat shock proteins 27, 60, 70, 90alpha, and
20S proteasome in on-pump versus off-pump coronary artery bypass graft patients.
Ann.Thorac.Surg. 2008; 85: 80-7
(19) Totsugawa T, Kuinose M, Yoshitaka H, Ishii S, Tsushima Y,
Ishida A: Intraoperative endotoxin adsorption as a new
therapeutic option for mycotic aortic aneurysm. Circ.J. 2008; 72: 161-3
(20) Vohra HA, Bapu D, Bahrami T, Gaer JA, Satur CM:
Does perioperative administration of thyroid hormones
improve outcome following coronary artery bypass grafting? J.Card Surg.
2008; 23: 92-6
(21) Warren OJ, Tunnicliffe CR, Massey RM, Wallace S, Smith AJ,
Alcock EM, Darzi A, Vincent CA, Athanasiou T: Systemic
leukofiltration does not attenuate pulmonary injury after cardiopulmonary bypass.
ASAIO J. 2008; 54: 78-88
08-10/2007
(1) Zhao X, Courtney JM,
Yin HQ, West RH, Lowe GD: Blood interactions with
plasticised poly (vinyl chloride): influence of surface modification.
J.Mater.Sci.Mater.Med. 2007; .:
(2) Warren O, Wallace S, Massey R,
Tunnicliffe C, Alexiou C, Powell J, Meisuria N, Darzi A, Athanasiou T:
Does systemic leukocyte filtration affect perioperative hemorrhage in cardiac
surgery? A systematic review and meta-analysis.
ASAIO J. 2007; 53: 514-21
(3) Takayama H, Soltow LO, Chandler WL, Vocelka CR, Aldea GS:
Does the type of surgery effect systemic response
following cardiopulmonary bypass? J.Card Surg. 2007;
22: 307-13
(4) Takayama H, Soltow LO, Aldea GS:
Differential expression in markers for thrombin, platelet
activation, and inflammation in cell saver versus systemic blood in patients
undergoing on-pump coronary artery bypass graft surgery.
J.Cardiothorac.Vasc.Anesth. 2007; 21: 519-23
(5) Suleiman MS, Zacharowski K, Angelini GD:
Inflammatory response and cardioprotection during open-heart
surgery: the importance of anaesthetics.
Br.J.Pharmacol. 2007; .:
(6) Sodha NR, Feng J, Clements RT, Bianchi C, Boodhwani M,
Ramlawi B, Mieno S, Khabbaz KR, Sellke FW: Protein
kinase C alpha modulates microvascular reactivity in the human coronary and
skeletal microcirculation. Surgery. 2007; 142:
243-52
(7) Schuerholz T, Marx G: Dextran-70
to modulate inflammatory response after cardiopulmonary bypass: potential for a
novel approach? Crit Care. 2007; 11: 163
(8) Robertson-Malt S, Afrane B, El Barbary M:
Prophylactic steroids for pediatric open heart surgery.
Cochrane.Database.Syst.Rev. 2007; CD005550
(9) Rasmussen BS, Laugesen H, Sollid J, Gronlund J, Rees SE,
Toft E, Gjedsted J, Dethlefsen C, Tonnesen E:
Oxygenation and release of inflammatory mediators after off-pump compared with
after on-pump coronary artery bypass surgery. Acta
Anaesthesiol.Scand. 2007; 51: 1202-10
(10) Raja SG, Berg GA: Impact of
off-pump coronary artery bypass surgery on systemic inflammation: current best
available evidence. J.Card Surg. 2007; 22: 445-55
(11) Ohki S, Oshima K, Takeyoshi I, Matsumoto K, Morishita Y:
Endotoxin Removal with a Polymyxin B-Immobilized
Hemoperfusion Cartridge Improves Cardiopulmonary Function After Cardiopulmonary
Bypass. J.Surg.Res. 2007; .:
(12) Lim HK, Anderson J, Leong JY, Pepe S, Salamonsen RF,
Rosenfeldt FL: What is the role of leukocyte
depletion in cardiac surgery? Heart Lung Circ. 2007;
16: 243-53
(13) Liakopoulos OJ, Schmitto JD, Kazmaier S, Brauer A, Quintel
M, Schoendube FA, Dorge H: Cardiopulmonary and
systemic effects of methylprednisolone in patients undergoing cardiac surgery.
Ann.Thorac.Surg. 2007; 84: 110-8
(14) Levy E, Korach A, Merin G, Feinsod M, Glenville B:
Pituitary apoplexy and CABG: should we change our strategy?
Ann.Thorac.Surg. 2007; 84: 1388-90
(15) Lazar HL, Keilani T, Fitzgerald CA, Shapira OM, Hunter CT,
Shemin RJ, Marsh HC, Jr., Ryan US: Beneficial
effects of complement inhibition with soluble complement receptor 1 (TP10)
during cardiac surgery: is there a gender difference?
Circulation. 2007; 116: I83-I88
(16) Kageyama K, Hashimoto S, Nakajima Y, Shime N, Hashimoto S:
The change of plasma endothelin-1 levels before and
after surgery with or without Down syndrome.
Paediatr.Anaesth. 2007; 17: 1071-7
(17) Jebali MA, Hausfater P, Abbes Z, Aouni Z, Riou B, Ferjani
M: Assessment of the accuracy of procalcitonin to
diagnose postoperative infection after cardiac surgery.
Anesthesiology. 2007; 107: 232-8
(18) Hsieh YJ, Wakiyama H, Levitsky S, McCully JD:
Cardioplegia and diazoxide modulate STAT3 activation and
DNA binding. Ann.Thorac.Surg. 2007; 84: 1272-8
(19) Heinze H, Rosemann C, Weber C, Heinrichs G, Bahlmann L,
Misfeld M, Heringlake M, Eichler W: A single
prophylactic dose of pentoxifylline reduces high dependency unit time in cardiac
surgery - a prospective randomized and controlled study.
Eur.J.Cardiothorac.Surg. 2007; 32: 83-9
(20) Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard
M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B,
MacAllister RJ, Yellon DM: Effect of remote
ischaemic preconditioning on myocardial injury in patients undergoing coronary
artery bypass graft surgery: a randomised controlled trial.
Lancet. 2007; 370: 575-9
(21) Hacquebard M, Ducart A, Schmartz D, Malaisse WJ,
Carpentier YA: Changes in Plasma LDL and HDL
Composition in Patients Undergoing Cardiac Surgery.
Lipids. 2007; .:
(22) Gombocz K, Beledi A, Alotti N, Kecskes G, Gabor V, Bogar
L, Koszegi T, Garai J: Influence of dextran-70 on
systemic inflammatory response and myocardial ischaemia-reperfusion following
cardiac operations. Crit Care. 2007; 11: R87
(23) Gasparovic H, Plestina S, Sutlic Z, Husedzinovic I, Coric
V, Ivancan V, Jelic I: Pulmonary lactate release
following cardiopulmonary bypass.
Eur.J.Cardiothorac.Surg. 2007; .:
(24) Fattouch K, Bianco G, Speziale G, Sampognaro R, Lavalle C,
Guccione F, Dioguardi P, Ruvolo G: Beneficial
effects of C1 esterase inhibitor in ST-elevation myocardial infarction in
patients who underwent surgical reperfusion: a randomised double-blind study.
Eur.J.Cardiothorac.Surg. 2007; 32: 326-32
(25) Coleman CI, Lucek DM, Hammond J, White CM:
Preoperative statins and infectious complications following
cardiac surgery. Curr.Med.Res.Opin. 2007; 23:
1783-90
(26) Coccia R, Spadaccio C, Foppoli C, Perluigi M, Covino E,
Lusini M, Chello M: The effect of simvastatin on
erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary
bypass: a randomized controlled study. Clin.Ther.
2007; 29: 1706-17
(27) Chello M, Spadaccio C, Patti G, Lusini M, Barbato R,
Goffredo C, Di Sciascio G, Covino E: Simvastatin
reduces platelet-endocardium adhesion in atrial fibrillation.
Atherosclerosis. 2007; .:
(28) Caso G, Vosswinkel JA, Garlick PJ, Barry MK, Bilfinger TV,
McNurlan MA: Altered protein metabolism following
coronary artery bypass graft (CABG) surgery.
Clin.Sci.(Lond). 2007; .:
(29) Bingyang J, Jinping L, Mingzheng L, Guyan W, Zhengyi F:
Effects of urinary protease inhibitor on
inflammatory response during on-pump coronary revascularisation. Effect of
ulinastatin on inflammatory response.
J.Cardiovasc.Surg.(Torino). 2007; 48: 497-503
(30) Augoustides JG: Management of
vasoplegia after cardiopulmonary bypass: role of prostaglandin inhibition.
Ann.Thorac.Surg. 2007; 84: 1796
(31) Asberg AE, Videm V: Inhibition
of platelet receptors involved in neutrophil-platelet interaction in model
cardiopulmonary bypass. Artif.Organs. 2007; 31:
617-26
(32) Alston RP: IL-18 and SC5b-9
for predicting neurocognitive dysfunction after cardiopulmonary bypass.
Br.J.Anaesth. 2007; 99: 444-5
(33) Ak K, Isbir S, Tekeli A, Ergen A, Atalan N, Dogan S,
Civelek A, Arsan S: Presence of lipoprotein lipase
S447X stop codon affects the magnitude of interleukin 8 release after cardiac
surgery with cardiopulmonary bypass.
J.Thorac.Cardiovasc.Surg. 2007; 134: 477-83
(34) Adib-Conquy M, Monchi M, Goulenok C, Laurent I, Thuong M,
Cavaillon JM, Adrie C: Increased plasma levels of
soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after
cardiac surgery and cardiac arrest without infection.
Shock. 2007; 28: 406-10
(35) Abdel-Rahman U, Margraf S, Aybek T, Loegters T, Moreno JB,
Francischetti I, Kranert T, Gruenwald F, Windolf J, Moritz A, Scholz M:
Inhibition of neutrophil activity improves cardiac function
after cardiopulmonary bypass. J.Inflamm.(Lond).
2007; 4: 21
05/2007
(1)
Wojtecka-Lukasik E, Karolczak MA, Maslinska D, Gujski M, Czuprynska K, Gruda K
et al. Histamine and oxygen radicals of blood in the
course of cardiopulmonary bypass (CPB). Inflamm Res
2006; 55(Supplement 1):S75-S76.
(2) Hadley JS, Wang JE, Michaels LC, Dempsey CM, Foster SJ,
Thiemermann C et al. ALTERATIONS IN INFLAMMATORY
CAPACITY AND TLR EXPRESSION ON MONOCYTES AND NEUTROPHILS AFTER CARDIOPULMONARY
BYPASS. Shock 2007; 27(5):466-473.
(3) Borrelli U, Al Attar N, Detroux M, Nottin R, Nikis S,
Jennes S et al. Compact extracorporeal circulation:
reducing the surface of cardiopulmonary bypass to improve outcomes.
Surg Technol Int 2007; 16:159-66.:159-166.
(4) Halonen J, Halonen P, Jarvinen O, Taskinen P, Auvinen T,
Tarkka M et al. Corticosteroids for the prevention
of atrial fibrillation after cardiac surgery: a randomized controlled trial.
JAMA 2007; 297(14):1562-1567.
(5) Rasmussen BS, Sollid J, Knudsen L, Christensen T, Toft E,
Tonnesen E. The release of systemic inflammatory
mediators is independent of cardiopulmonary bypass temperature.
J Cardiothorac Vasc Anesth 2007; 21(2):191-196.
(6) Tassani P, Schad H, Schreiber C, Zaccaria F, Haas F,
Mossinger H et al. Extravasation of albumin after
cardiopulmonary bypass in newborns. J Cardiothorac
Vasc Anesth 2007; 21(2):174-178.
(7) Vincelj J, Sokol I, Pevec D, Sutlic Z.
Infective endocarditis of aortic valve during pregnancy: A
case report. Int J Cardiol 2007; .
(8) Turk T, Vural H, Eris C, Ata Y, Yavuz S.
Atrial fibrillation after off-pump coronary artery surgery:
a prospective, matched study. J Int Med Res 2007;
35(1):134-142.
(9) Braun JP, Buhner S, Kastrup M, Dietz E, Langer K, Dohmen PM
et al. Barrier function of the gut and multiple
organ dysfunction after cardiac surgery. J Int Med
Res 2007; 35(1):72-83.
(10) Borgermann J, Flohe S, Scheubel RJ, Kuss O, Simm A, Schade
FU et al. Regulation of cytokine synthesis in
cardiac surgery: Role of extracorporeal circuit and humoral mediators in vivo
and in vitro. Inflamm Res 2007; 56(3):126-132.
(11) Karth GD, Buberl A, Nikfardjam M, Meyer B, Wollenek G,
Grimm M et al. Role of amiodarone on the systemic
inflammatory response induced by cardiac surgery: proinflammatory actions: [Role
de l'amiodarone sur la reaction inflammatoire systemique provoquee par la
chirurgie cardiaque : actions pro-inflammatoires].
Can J Anaesth 2007; 54(4):262-268.
(12) Healy DG, Wood AE, O'neill A, McCarthy JF, Fitzpatrick JM,
Watson RW. Can preoperative modelling of individual
neutrophil adhesion responses predict renal morbidity?
Eur J Cardiothorac Surg 2007; .
(13) VandenBerg SD, Hutchison JS, Parshuram CS.
A cross-sectional survey of levels of care and response mechanisms for evolving
critical illness in hospitalized children.
Pediatrics 2007; 119(4):e940-e946.
(14) Baig K, Nassar R, Craig DM, Quick G, Jr., Jiang HX, Frank
MM et al. Complement factor 1 inhibitor improves
cardiopulmonary function in neonatal cardiopulmonary bypass.
Ann Thorac Surg 2007; 83(4):1477-1482.
(15) Chello M, Anselmi A, Spadaccio C, Patti G, Goffredo C, Di
Sciascio G et al. Simvastatin increases neutrophil
apoptosis and reduces inflammatory reaction after coronary surgery.
Ann Thorac Surg 2007; 83(4):1374-1380.
(16) Varnous S, Ben Ayed S, Masliah J, Leprince P, Gandjbakhch
I, Bernard M et al. Secretory phospholipase A(2)
activity and release kinetics of vascular tissue remodelling biomarkers after
coronary artery bypass grafting with and without cardiopulmonary bypass.
Clin Chem Lab Med 2007; 45(3):372-375.
(17) Hatherill M, Salie S, Waggie Z, Lawrenson J, Hewitson J,
Reynolds L et al. The lactate:pyruvate ratio
following open cardiac surgery in children.
Intensive Care Med 2007; .
(18) Metallidis S, Nikolaidis J, Lazaraki G, Koumentaki E,
Gogou V, Topsis D et al. Penetration of linezolid
into sternal bone of patients undergoing cardiopulmonary bypass surgery.
Int J Antimicrob Agents 2007; .
(19) Lim HK, Anderson J, Leong JY, Pepe S, Salamonsen RF,
Rosenfeldt FL. What is the Role of Leukocyte
Depletion in Cardiac Surgery? Heart Lung Circ 2007;
.
(20) Ozkara C, Guler N, Batyraliev T, Okut H, Agirbasli M.
Does off-pump coronary artery bypass surgery reduce
secretion of plasminogen activator inhibitor-1? Int
J Clin Pract 2007; .
(21) Kovacevic M, Simic O, Jonjic N, Stifter S.
Apoptosis and cardiopulmonary bypass.
J Card Surg 2007; 22(2):129-134.
(22) Otaki M, Omiya H, Matsumoto T, Inoue T, Kaneda T, Kitayama
H et al. Candida endocarditis in association with
myelodysplastic syndromes: review of the literature and report of a case.
J Med 1999; 30(3-4):176-184.
(23) Kim WG, Sung K, Seo JW. Time-related
histopathologic analyses of immunologically untreated porcine valved conduits
implanted in a porcine-to-goat model. Artif Organs
2007; 31(2):105-113.
(24) O'Malley CM, Frumento RJ, Mackie IJ, Gallimore MJ, Hirsh
AL, Bennett-Guerrero E. The role of endogenous
kallikrein inhibition in perioperative transfusion and adverse outcome in
cardiac surgical patients. J Cardiothorac Vasc
Anesth 2007; 21(1):23-27.
(25) Borgermann J, Friedrich I, Scheubel R, Kuss O, Lendemans
S, Silber RE et al. Granulocyte-macrophage colony-stimulating
factor (GM-CSF) restores decreased monocyte HLA-DR expression after
cardiopulmonary bypass. Thorac Cardiovasc Surg 2007;
55(1):24-31.
(26) Goudeau JJ, Clermont G, Guillery O, Lemaire-Ewing S, Musat
A, Vernet M et al. In high-risk patients,
combination of antiinflammatory procedures during cardiopulmonary bypass can
reduce incidences of inflammation and oxidative stress.
J Cardiovasc Pharmacol 2007; 49(1):39-45.
(27) Vandijck DM, Blot SI, Poelaert JI.
Microbiologically documented nosocomial infections after
coronary artery bypass surgery without cardiopulmonary bypass.
J Thorac Cardiovasc Surg 2007; 133(2):590-591.
(28) Landis RC. Protease activated
receptors: clinical relevance to hemostasis and inflammation.
Hematol Oncol Clin North Am 2007; 21(1):103-113.
(29) Levy JH. Anti-inflammatory
strategies and hemostatic agents: old drugs, new ideas.
Hematol Oncol Clin North Am 2007; 21(1):89-101.
(30) Roberts N, Xiao Q, Weir G, Xu Q, Jahangiri M.
Endothelial progenitor cells are mobilized after cardiac
surgery. Ann Thorac Surg 2007; 83(2):598-605.
(31) Wang LZ, Li ST, Wang YT, Wang ZP.
Antioxidant Attenuates Acute Lung Injury After
Cardiopulmonary Bypass in Rats. Asian Cardiovasc
Thorac Ann 2007; 15(1):2-8.
(32) Warren O, Alexiou C, Massey R, Leff D, Purkayastha S,
Kinross J et al. The effects of various leukocyte
filtration strategies in cardiac surgery. Eur J
Cardiothorac Surg 2007; 31(4):665-676.
(33) Lechner E, Hofer A, Mair R, Moosbauer W, Sames-Dolzer E,
Tulzer G. Arginine-vasopressin in neonates with
vasodilatory shock after cardiopulmonary bypass. Eur
J Pediatr 2007; .
(34) Mazer CD, Briet F, Blight KR, Stewart DJ, Robb M, Wang Z
et al. Increased cerebral and renal endothelial
nitric oxide synthase gene expression after cardiopulmonary bypass in the rat.
J Thorac Cardiovasc Surg 2007; 133(1):13-20.
01/2007
(1) 1. Fontana M, Ruchat P, Horisberger J, Aubert V, Mayor C, Spertini F:
Prevention of cryoprecipitation during cardiopulmonary bypass in a patient with HIV-HCV co-infections. Perfusion. 2006; 21: 263-5 09/2006
(1) Ajzan A, Modine T, Punjabi P,
Ganeshalingam K, Philips G, Gourlay T. Quantification of fat
mobilization in patients undergoing coronary artery revascularization using off-pump
and on-pump techniques. J Extra Corpor Technol 2006; 38(2):116-121. 04/2006
(1) Aitio ML.
N-acetylcysteine -- passe-partout or much ado about nothing? Br J Clin
Pharmacol 2006; 61(1):5-15.
12/2005
(1) Bittner
HB, Richter M, Kuntze T, Rahmel A, Dahlberg P, Hertz M et al. Aprotinin
decreases reperfusion injury and allograft dysfunction in clinical lung
transplantation. Eur J Cardiothorac Surg 2005; . 08/2005
(1) Checchia PA, Bronicki RA, Costello JM,
Nelson DP. Steroid use before pediatric cardiac operations using
cardiopulmonary bypass: an international survey of 36 centers. Pediatr Crit
Care Med 2005; 6(4):441-444.
07/2005
(1) Alcaraz AJ, Manzano L, Sancho L,
Vigil MD, Esquivel F, Maroto E et al. Different proinflammatory cytokine
serum pattern in neonate patients undergoing open heart surgery. Relevance of
IL-8. J Clin Immunol 2005; 25(3):238-245. 05/2005
1. Lo B, Fijnheer R, Nierich AP, Bruins
P, Kalkman CJ: C-reactive protein is a risk indicator for atrial fibrillation
after myocardial revascularization. Ann.Thorac.Surg.2005; 79: 1530-5 03/2005
(1) Alexiou C, Tang AT, Sheppard SV, Haw
MP, Gibbs R, Smith DC. A prospective randomized study to evaluate the effect
of leukodepletion on the rate of alveolar production of exhaled nitric oxide
during cardiopulmonary bypass. Ann Thorac Surg 2004; 78(6):2139-2145.
(2) Luo WJ, Qian JF, Jiang HH: Pretreatment with aminophylline reduces release of Troponin I and neutrophil activation in the myocardium of patients undergoing cardioplegic arrest. Eur.J.Cardiothorac.Surg. 2006; .:
(3) Alaoja H, Niemela E, Anttila V, Dahlbacka S, Makela J, Kiviluoma K, Laurila P, Kaakinen T, Juvonen T:
Leukocyte filtration to decrease the number of adherent leukocytes in the cerebral microcirculation after a period of deep hypothermic circulatory arrest. J.Thorac.Cardiovasc.Surg. 2006; 132: 1339-47
(4) Ranucci M, De Toffol B, Isgro G, Romitti F, Conti D, Vicentini M:
Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care. 2006; 10: R167
(5) Sbrana S, Buffa M, Bevilacqua S, Spiller D, Parri MS, Gianetti J, De Filippis R, Clerico A:
Granulocyte- and monocyte-platelet adhesion index in coronary and peripheral blood after extracorporeal circulation and reperfusion. Cytometry B Clin.Cytom. 2006; .:
(6)Sano T, Morita S, Masuda M, Yasui H: Minor infection encouraged by steroid administration during cardiac surgery. Asian Cardiovasc.Thorac.Ann. 2006; 14: 505-10
(7) Menardi AC, Viaro F, Vicente WV, Rodrigues AJ, Evora PR:
Hemodynamic and vascular endothelium function studies in healthy pigs after intravenous bolus infusion of methylene blue. Arq Bras.Cardiol. 2006; 87: 525-32
(8) Hoda MR, El Achkar H, Schmitz E, Scheffold T, Vetter HO, De Simone R:
Systemic stress hormone response in patients undergoing open heart surgery with or without cardiopulmonary bypass. Ann.Thorac.Surg. 2006; 82: 2179-86
(9) Stuart-Andrews C, Peyton P, Robinson G, Terry D, O'Connor B, Van der HC, Lithgow B:
Non-invasive metabolic monitoring of patients under anaesthesia by continuous indirect calorimetry--an in vivo trial of a new method. Br.J.Anaesth. 2007; 98: 45-52
(10) Kotani T, Kotake Y, Morisaki H, Takeda J, Shimizu H, Ueda T, Ishizaka A:
Activation of a neutrophil-derived inflammatory response in the airways during cardiopulmonary bypass. Anesth.Analg. 2006; 103: 1394-9
(11) Murphy TW, Homewood J, McCabe A, Humphreys N, Wolf AR:
Evidence of cortisol suppression in neonates after major cardiac surgery: is supplementation necessary?
Paediatr.Anaesth. 2006; 16: 1297
(12) Karu I, Zilmer K, Starkopf J, Zilmer M: Changes of plasma asymmetric dimethylarginine levels after coronary artery bypass grafting. Scand.Cardiovasc.J. 2006; 40: 363-7
(13)Zhang J, Krishnan R, Arnold CS, Mattsson E, Kilpatrick JM, Bantia S, Dehghani A, Boudreaux B, Gupta SN, Kotian PL, Chand P, Babu YS:
Discovery of highly potent small molecule kallikrein inhibitors. Med.Chem. 2006; 2: 545-53
(14) Brown DM, Holt DW, Edwards JT, Burnett RJ, III: Normoxia vs. hyperoxia: impact of oxygen tension strategies on outcomes for patients receiving cardiopulmonary bypass for routine cardiac surgical repair. J.Extra.Corpor.Technol. 2006; 38: 241-8
(15)Langley J, Adams G: Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review.
Diabetes Metab Res.Rev. 2006; .:
(16) Li JS, Jaggers J, Anderson PA: The use of TP10, soluble complement receptor 1, in cardiopulmonary bypass. Expert.Rev.Cardiovasc.Ther. 2006; 4: 649-54
(17) Breuer JP, von D, V, von Heymann C, Griesbach M, von Schickfus M, Mackh E, Hacker C, Elgeti U, Konertz W, Wernecke KD, Spies CD:
Preoperative oral carbohydrate administration to ASA III-IV patients undergoing elective cardiac surgery. Anesth.Analg. 2006; 103: 1099-108
(18) Hogue CW, London MJ: Aprotinin use during cardiac surgery: a new or continuing controversy?
Anesth.Analg. 2006; 103: 1067-70
(19) Franke A, Lante W, Markewitz A, Weinhold C: In vitro restoration of post-operatively decreased IFN-gamma levels after cardiac surgery and its effect on pro- and anti-inflammatory mediators. J.Surg.Res. 2006; 136: 266-72
(20) Metallidis S, Charokopos N, Nikolaidis J, Alexiadou E, Lazaraki G, Koumentaki E, Tsona A, Theodoridis G, Nikolaidis P:
Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery. Int.J.Antimicrob.Agents. 2006; 28: 428-32
(21) Corcoran TB, Engel A, Sakamoto H, O'Shea A, O'Callaghan-Enright S, Shorten GD:
The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br.J.Anaesth. 2006; 97: 825-31
(22) Oh YJ, Lee JH, Nam SB, Shim JK, Song JH, Kwak YL:
Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass. Br.J.Anaesth. 2006; 97: 792-8
(23) Hubert B, Troncy E, Gauvin D, Taha R, Pang D, Beauchamp G, Radomski A, Radomski MW, Blaise GA:
Increased alveolar and plasma gelatinases activity during postpump syndrome: inhibition by inhaled nitric oxide. J.Cardiovasc.Pharmacol. 2006; 48: 71-8
(24) Asberg AE, Videm V: Neutrophil dysfunction after biomaterial contact in an in vitro model of cardiopulmonary bypass. Eur.J.Cardiothorac.Surg. 2006; 30: 744-8
(25) Svenmarker S, Haggmark S, Ostman M: What is a normal lactate level during cardiopulmonary bypass?
Scand.Cardiovasc.J. 2006; 40: 305-11
(26) Berg K, Haaverstad R, Astudillo R, Bjorngaard M, Skarra S, Wiseth R, Basu S, Jynge P:
Oxidative stress during coronary artery bypass operations: importance of surgical trauma and drug treatment.
Scand.Cardiovasc.J. 2006; 40: 291-7
(27) Kunt AS, Selek S, Celik H, Demir D, Erel O, Andac MH:
Decrease of total antioxidant capacity during coronary artery bypass surgery. Mt.Sinai J.Med. 2006; 73: 777-83
(28) Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, Di Sciascio G: Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006; 114: 1455-61
(29) Anttila V, Hagino I, Iwata Y, Mettler BA, Lidov HG, Zurakowski D, Jonas RA:
Aprotinin improves cerebral protection: evidence from a survival porcine model. J.Thorac.Cardiovasc.Surg. 2006; 132: 948-53
(30) Tatoulis J, Rice S, Davis P, Goldblatt JC, Marasco S:
Patterns of postoperative systemic vascular resistance in a randomized trial of conventional on-pump versus off-pump coronary artery bypass graft surgery. Ann.Thorac.Surg. 2006; 82: 1436-44
(31) Strecker T, Dieterle A, Reeh PW, Weyand M, Messlinger K:
Stimulated release of calcitonin gene-related peptide from the human right atrium in patients with and without diabetes mellitus. Peptides. 2006; 27: 3255-60
(32) Khilnani P, Sarma D, Zimmerman J: Epidemiology and peculiarities of pediatric multiple organ dysfunction syndrome in new delhi, India. Intensive Care Med. 2006; 32: 1856-62
(33) Furusawa T, Tsukioka K, Fukui D, Sakaguchi M, Seto T, Terasaki T, Wada Y, Amano J:
The effects of a neutrophil elastase inhibitor on the postoperative respiratory failure of acute aortic dissection. Thorac.Cardiovasc.Surg. 2006; 54: 404-7
(34) Lull ME, Freeman WM, Myers JL, Midgley F, Kimatian SJ, Undar A, Vrana KE:
Plasma proteomics: a noninvasive window on pathology and pediatric cardiac surgery. ASAIO J. 2006; 52: 562-6
(35) McMonagle MP, Halpenny M, McCarthy A, Mortell A, Manning F, Kilty C, Mannion D, Wood AE, Corbally MT:
Alpha glutathione S-transferase: a potential marker of ischemia-reperfusion injury of the intestine after cardiac surgery? J.Pediatr.Surg. 2006; 41: 1526-31
(36) Karlidag R, Unal S, Sezer OH, Bay KA, Battaloglu B, But A, Ozcan C:
The role of oxidative stress in postoperative delirium. Gen.Hosp.Psychiatry. 2006; 28: 418-23
(37) Dvorak L, Pirk J, Cerny S, Kovar J: The role of leukocyte depleting filters in heart transplantation: early outcomes in prospective, randomized clinical trial.
Eur.J.Cardiothorac.Surg. 2006; 30: 621-7
(38) Iskesen I, Saribulbul O, Cerrahoglu M, Var A, Nazli Y, Sirin H: Trimetazidine reduces oxidative stress in cardiac surgery. Circ.J. 2006; 70: 1169-73
(39) Falagas ME, Rosmarakis ES, Rellos K, Michalopoulos A, Samonis G, Prapas SN:
Microbiologically documented nosocomial infections after coronary artery bypass surgery without cardiopulmonary bypass. J.Thorac.Cardiovasc.Surg. 2006; 132: 481-90
(40) Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I, Klein NJ: Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med. 2006; 34: 2658-65
(41) Koskenkari JK, Kaukoranta PK, Rimpilainen J, Vainionpaa V, Ohtonen PP, Surcel HM, Juvonen T, Ala-Kokko TI: Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery. Acta Anaesthesiol.Scand. 2006; 50: 962-9
(42) van Wezel HB, Zuurbier CJ, de Jonge E, van Dam EW, van Dijk J, Endert E, de Mol BA, Fliers E:
Differential effects of a perioperative hyperinsulinemic normoglycemic clamp on the neurohumoral stress response during coronary artery surgery. J.Clin.Endocrinol.Metab. 2006; 91: 4144-53
(43) Stevens LM, Fortier S, Aubin MC, El Hamamsy I, Maltais S, Carrier M, Perrault LP:
Effect of tetrahydrobiopterin on selective endothelial dysfunction of epicardial porcine coronary arteries induced by cardiopulmonary bypass.
Eur.J.Cardiothorac.Surg. 2006; 30: 464-71
(44) Levy JH: Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: yes. J.Thromb.Haemost. 2006; 4: 1875-8
(45) Karkouti K, Beattie WS: Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: no. J.Thromb.Haemost. 2006; 4: 1879-81
(46) Oshima K, Takeyoshi I, Tsutsumi H, Mohara J, Ohki S, Koike N, Nameki T, Matsumoto K, Morishita Y:
Inhibition of cyclooxygenase-2 improves cardiac function following long-term preservation.
J.Surg.Res. 2006; 135: 380-4
(47) Krizanac-Bengez L, Hossain M, Fazio V, Mayberg M, Janigro D:
Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines. Am.J.Physiol Cell Physiol. 2006; 291: C740-C749
(2) Akila, D'souza B, Vishwanath P, D'souza V.
Oxidative injury and antioxidants in coronary artery bypass graft surgery: Off-pump
CABG significantly reduces oxidative stress. Clin Chim Acta 2006; .
(3) Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I et
al. Interleukin-10 and its role in clinical immunoparalysis
following pediatric cardiac surgery*. Crit Care Med 2006; .
(4) Bartoc C, Frumento RJ, Jalbout M, Bennett-Guerrero E, Du E, Nishanian
E. A randomized, double-blind, placebo-controlled study
assessing the anti-inflammatory effects of ketamine in cardiac surgical patients.
J Cardiothorac Vasc Anesth 2006; 20(2):217-222.
(5) Belway D, Rubens FD. Currently available
biomaterials for use in cardiopulmonary bypass. Expert Rev Med Devices
2006; 3(3):345-355.
(6) Bical OM, Fromes Y, Gaillard D, Fischer M, Ponzio O, Deleuze P et al.
Comparison of the inflammatory response between miniaturized
and standard CPB circuits in aortic valve surgery. Eur J Cardiothorac
Surg 2006; 29(5):699-702.
(7) Brkic K, Unic D, Sutlic Z, Biocina B, Rudez I, Baric D et al.
Neopterin kinetics after cardiac surgery with or without
cardiopulmonary bypass. Coll Antropol 2006; 30(2):395-400.
(8) Carrier M, Denault A, Lavoie J, Perrault LP.
Randomized controlled trial of pericardial blood processing with a cell-saving
device on neurologic markers in elderly patients undergoing coronary artery
bypass graft surgery. Ann Thorac Surg 2006; 82(1):51-55.
(9) Celebi S, Koner O, Menda F, Balci H, Hatemi A, Korkut K et al.
Procalcitonin kinetics in pediatric patients with systemic
inflammatory response after open heart surgery. Intensive Care Med 2006;
32(6):881-887.
(10) Collard CD, Body SC, Shernan SK, Wang S, Mangano DT.
Preoperative statin therapy is associated with reduced
cardiac mortality after coronary artery bypass graft surgery. J Thorac
Cardiovasc Surg 2006; 132(2):392-400.
(11) Cooper JR, Jr., Abrams J, Frazier OH, Radovancevic R, Radovancevic
B, Bracey AW et al. Fatal pulmonary microthrombi during
surgical therapy for end-stage heart failure: possible association with
antifibrinolytic therapy. J Thorac Cardiovasc Surg 2006; 131(5):963-968.
(12) De Silva RJ, Vuylsteke A, Fritchley SJ, Trull AK, Dunning JJ,
Wallwork J. APT070 inhibits complement activation during in
vitro cardiopulmonary bypass. Eur J Cardiothorac Surg 2006; 30(1):72-76.
(13) Dong X, Liu Y, Du M, Wang Q, Yu CT, Fan X. P38
mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory
response in a rat cardiopulmonary bypass model. Eur J Cardiothorac Surg
2006; 30(1):77-84.
(14) Duggan E, Caraher E, Gately K, O'Dwyer M, McGovern E, Kelleher D et
al. Tumor necrosis factor-alpha and interleukin-10 gene
expression in peripheral blood mononuclear cells after cardiac surgery.
Crit Care Med 2006; 34(8):2134-2139.
(15) Franke A, Lante W, Kurig E, Zoller LG, Weinhold C, Markewitz A.
Hyporesponsiveness of T cell subsets after cardiac surgery: a
product of altered cell function or merely a result of absolute cell count
changes in peripheral blood? Eur J Cardiothorac Surg 2006; 30(1):64-71.
(16) Franke A, Lante W, Kurig E, Zoller LG, Weinhold C, Markewitz A.
Is interferon gamma suppression after cardiac surgery caused
by a decreased interleukin-12 synthesis? Ann Thorac Surg 2006;
82(1):103-109.
(17) Gasz B, Lenard L, Racz B, Benko L, Borsiczky B, Cserepes B et al.
Effect of cardiopulmonary bypass on cytokine network and
myocardial cytokine production. Clin Cardiol 2006; 29(7):311-315.
(18) Grano V, Salamino F, Melloni E, Minafra R, Regola E, Diano N et al.
Biotechnological traps for the reduction of inflammation due
to cardiopulmonary bypass operations. Biomaterials 2006;
27(20):3855-3862.
(19) Grosek S, Primozic J, Ihan A, Wraber B, Gabrijelcic T, Kosin M.
Interleukin-10, T-lymphocytes, and cardiac output in children
after ventricular septal defect repair: a pilot study. Intensive Care Med
2006; 32(5):780-784.
(20) Harper S, Hosgood S, Kay M, Nicholson M.
Leucocyte depletion improves renal function during reperfusion using an
experimental isolated haemoperfused organ preservation system. Br J Surg
2006; 93(5):623-629.
(21) Hickey E, Karamlou T, You J, Ungerleider RM.
Effects of circuit miniaturization in reducing inflammatory response to infant
cardiopulmonary bypass by elimination of allogeneic blood products. Ann
Thorac Surg 2006; 81(6):S2367-S2372.
(22) Hogue CW, Jr., Palin CA, Kailasam R, Lawton JS, Nassief A, Davila-Roman
VG et al. C-reactive protein levels and atrial fibrillation
after cardiac surgery in women. Ann Thorac Surg 2006; 82(1):97-102.
(23) Hsing CH, Hsieh MY, Chen WY, Cheung SE, Cheng BC, Chang MS.
Induction of interleukin-19 and interleukin-22 after cardiac
surgery with cardiopulmonary bypass. Ann Thorac Surg 2006;
81(6):2196-2201.
(24) Isaka M, Imamura M, Sakuma I, Makino Y, Shiiya N, Yasuda K.
Cardiopulmonary bypass influences the plasma levels of
calcitonin gene-related peptides in dogs: Effects of hemofiltration and
hemodilution. Res Vet Sci 2006; .
(25) Iskesen I, Saribulbul O, Cerrahoglu M, Var A, Nazli Y, Sirin H.
Trimetazidine reduces oxidative stress in cardiac surgery.
Circ J 2006; 70(9):1169-1173.
(26) Kacila M, Bevilaqua S, Matteucci S, Solinas M, Farnetti A, Jacopo G
et al. Inflammatory and metabolic response of the myocardium
during aortic valve surgery on the beating heart. Bosn J Basic Med Sci
2006; 6(2):59-62.
(27) Koskenkari JK, Kaukoranta PK, Rimpilainen J, Vainionpaa V, Ohtonen
PP, Surcel HM et al. Anti-inflammatory effect of high-dose
insulin treatment after urgent coronary revascularization surgery. Acta
Anaesthesiol Scand 2006; 50(8):962-969.
(28) Kozik DJ, Tweddell JS. Characterizing the
inflammatory response to cardiopulmonary bypass in children. Ann Thorac
Surg 2006; 81(6):S2347-S2354.
(29) Krizanac-Bengez L, Hossain M, Fazio V, Mayberg M, Janigro D.
Loss of Flow Induces Leukocyte-mediated MMP/TIMP Imbalance in
Dynamic in vitro Blood-Brain Barrier Model: Role of Pro-inflammatory Cytokines.
Am J Physiol Cell Physiol 2006; .
(30) Lehmann LE, Schroeder S, Hartmann W, Dewald O, Book M, Weber SU et
al. A single nucleotide polymorphism of macrophage migration
inhibitory factor is related to inflammatory response in coronary bypass surgery
using cardiopulmonary bypass. Eur J Cardiothorac Surg 2006; 30(1):59-63.
(31) Liakopoulos OJ, Dorge H, Schmitto JD, Nagorsnik U, Grabedunkel J,
Schoendube FA. Effects of preoperative statin therapy on
cytokines after cardiac surgery. Thorac Cardiovasc Surg 2006;
54(4):250-254.
(32) Liakopoulos OJ, Teucher N, Muhlfeld C, Middel P, Heusch G,
Schoendube FA et al. Prevention of TNFalpha-associated
myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic
arrest by glucocorticoid treatment. Eur J Cardiothorac Surg 2006;
30(2):263-270.
(33) Maciver RH, Stewart R, Frederiksen JW, Fullerton DA, Horvath KA.
Topical application of bacitracin ointment is associated with
decreased risk of mediastinitis after median sternotomy. Heart Surg Forum
2006; 9(5):E750-E753.
(34) Madhok AB, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D.
Cytokine response in children undergoing surgery for
congenital heart disease. Pediatr Cardiol 2006; 27(4):408-413.
(35) Michalopoulos A, Geroulanos S, Rosmarakis ES, Falagas ME.
Frequency, characteristics, and predictors of
microbiologically documented nosocomial infections after cardiac surgery.
Eur J Cardiothorac Surg 2006; 29(4):456-460.
(36) Mieno S, Ramlawi B, Boodhwani M, Clements RT, Minamimura K, Maki T
et al. Role of stromal-derived factor-1alpha in the induction
of circulating CD34+CXCR4+ progenitor cells after cardiac surgery.
Circulation 2006; 114(1 Suppl):I186-I192.
(37) Moretti EW, Newman MF, Muhlbaier LH, Whellan D, Petersen RP,
Rossignol D et al. Effects of decreased preoperative
endotoxin core antibody levels on long-term mortality after coronary artery
bypass graft surgery. Arch Surg 2006; 141(7):637-641.
(38) Najmaii S, Redford D, Larson DF. Hyperglycemia as
an effect of cardiopulmonary bypass: intra-operative glucose management.
J Extra Corpor Technol 2006; 38(2):168-173.
(39) Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. The
role of complement in biomaterial-induced inflammation. Mol Immunol 2006;
.
(40) Okum EJ, Perez-Tamayo RA, Higgins RS, Kasirajan V, Flattery M,
Crowley S. Administration of rabbit anti-thymocyte globulin
during cardiopulmonary bypass: a novel approach to the highly sensitized cardiac
transplant patient. J Heart Lung Transplant 2006; 25(5):608-610.
(41) Pendse SS, Vadivel N, Ramos E, Mudge GH, Von Visger T, Fang JC et
al. BK viral reactivation in cardiac transplant patients:
evidence for a double-hit hypothesis. J Heart Lung Transplant 2006;
25(7):814-819.
(42) Podgoreanu MV, White WD, Morris RW, Mathew JP, Stafford-Smith M,
Welsby IJ et al. Inflammatory gene polymorphisms and risk of
postoperative myocardial infarction after cardiac surgery. Circulation
2006; 114(1 Suppl):I275-I281.
(43) Raja SG, Yousufuddin S, Rasool F, Nubi A, Danton M, Pollock J.
Impact of modified ultrafiltration on morbidity after
pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2006;
14(4):341-350.
(44) Ramlawi B, Rudolph JL, Mieno S, Feng J, Boodhwani M, Khabbaz K et
al. C-Reactive protein and inflammatory response associated
to neurocognitive decline following cardiac surgery. Surgery 2006;
140(2):221-226.
(45) Ranucci M. The endothelial function in cardiac
surgery. Minerva Anestesiol 2006; 72(6):503-506.
(46) Riha H, Hubacek JA, Poledne R, Kellovsky P, Brezina A, Pirk J.
IL-10 and TNF-beta gene polymorphisms have no major influence
on lactate levels after cardiac surgery. Eur J Cardiothorac Surg 2006;
30(1):54-58.
(47) Rinder CS, Rinder HM, Smith MJ, Fitch JC, Tracey JB, Chandler WL et
al. Antithrombin reduces monocyte and neutrophil CD11b up
regulation in addition to blocking platelet activation during extracorporeal
circulation. Transfusion 2006; 46(7):1130-1137.
(48) Sander M, von Heymann C, von D, V, Spaethe C, Konertz WF, Jain U et
al. Increased interleukin-6 after cardiac surgery predicts
infection. Anesth Analg 2006; 102(6):1623-1629.
(49) Sano T, Masuda M, Morita S, Yasui H.
Prostaglandin E1 attenuates impairment of cellular immunity after
cardiopulmonary bypass. Jpn J Thorac Cardiovasc Surg 2006; 54(4):149-154.
(50) Schmid FX, Floerchinger B, Vudattu NK, Eissner G, Haubitz M, Holler
E et al. Direct evidence of endothelial injury during
cardiopulmonary bypass by demonstration of circulating endothelial cells.
Perfusion 2006; 21(3):133-137.
(51) Schmid FX, Vudattu N, Floerchinger B, Hilker M, Eissner G, Hoenicka
M et al. Endothelial apoptosis and circulating endothelial
cells after bypass grafting with and without cardiopulmonary bypass. Eur
J Cardiothorac Surg 2006; 29(4):496-500.
(52) Schneider C, Volk T. Endothelial Ca2+ signal
transduction is altered by postoperative serum from patients undergoing coronary
surgery with cardiopulmonary bypass. Anesth Analg 2006; 102(6):1630-1637.
(53) Sirgo G, Perez-Vela JL, Morales P, Del Rey M, Vendrell J, Gutierrez
C et al. Association between 4G/5G polymorphism of the
plasminogen activator inhibitor 1 gene with stroke or encephalopathy after
cardiac surgery. Intensive Care Med 2006; 32(5):668-675.
(54) Skrabal CA, Choi YH, Kaminski A, Steiner M, Kundt G, Steinhoff G et
al. Circulating endothelial cells demonstrate an attenuation
of endothelial damage by minimizing the extracorporeal circulation. J
Thorac Cardiovasc Surg 2006; 132(2):291-296.
(55) Stevens LM, Fortier S, Aubin MC, El Hamamsy I, Maltais S, Carrier M
et al. Effect of tetrahydrobiopterin on selective endothelial
dysfunction of epicardial porcine coronary arteries induced by cardiopulmonary
bypass. Eur J Cardiothorac Surg 2006; 30(3):464-471.
(56) van Wezel HB, Zuurbier CJ, de Jonge E, van Dam EW, van Dijk J,
Endert E et al. Differential effects of a perioperative
hyperinsulinemic normoglycemic clamp on the neurohumoral stress response during
CABG. J Clin Endocrinol Metab 2006; .
(57) Whitlock RP, Young E, Noora J, Farrokhyar F, Blackall M, Teoh KH.
Pulse low dose steroids attenuate post-cardiopulmonary bypass
SIRS; SIRS I. J Surg Res 2006; 132(2):188-194.
(58) Yates AR, Dyke PC, Taeed R, Hoffman TM, Hayes J, Feltes TF et al.
Hyperglycemia is a marker for poor outcome in the
postoperative pediatric cardiac patient. Pediatr Crit Care Med 2006;
7(4):351-355.
(59) Zimmermann AK, Weber N, Aebert H, Ziemer G, Wendel HP.
Effect of biopassive and bioactive surface-coatings on the
hemocompatibility of membrane oxygenators. J Biomed Mater Res B Appl
Biomater 2006;
(2) Arkader R, Troster EJ, Lopes MR, Junior RR, Carcillo JA, Leone C et
al. Procalcitonin does discriminate between sepsis and
systemic inflammatory response syndrome. Arch Dis Child 2006;
91(2):117-120.
(3) Baufreton C, Corbeau JJ, Pinaud F. [Inflammatory
response and haematological disorders in cardiac surgery: toward a more
physiological cardiopulmonary bypass.]. Ann Fr Anesth Reanim 2006; .
(4) Baufreton C. More biocompatibility in
cardiopulmonary bypass for high-risk patients. Ann Thorac Surg 2006;
81(2):790-791.
(5) Bittner HB, Richter M, Kuntze T, Rahmel A, Dahlberg P, Hertz M et al.
Aprotinin decreases reperfusion injury and allograft
dysfunction in clinical lung transplantation. Eur J Cardiothorac Surg
2006; 29(2):210-215.
(6) Day JR, Taylor KM, Lidington EA, Mason JC, Haskard DO, Randi AM et
al. Aprotinin inhibits proinflammatory activation of
endothelial cells by thrombin through the protease-activated receptor 1.
J Thorac Cardiovasc Surg 2006; 131(1):21-27.
(7) Golbasi I, Akbas H, Ozdem S, Ukan S, Ozdem SS, Kabukcu H et al.
The effect of pentoxifylline on haemolysis during
cardiopulmonary bypass in open-heart surgery. Acta Cardiol 2006;
61(1):7-11.
(8) Michalik DE, Duncan BW, Mee RB, Worley S, Goldfarb J, Danziger-Isakov
LA et al. Quantitative analysis of procalcitonin after
pediatric cardiothoracic surgery. Cardiol Young 2006; 16(1):48-53.
(9) Ng CS, Wan S, Arifi AA, Yim AP. Inflammatory
response to pulmonary ischemia-reperfusion injury. Surg Today 2006;
36(3):205-214.
(10) Osaka M, Aoyagi K, Hirakawa A, Nakajima M, Jikuya T, Shigeta O et
al. Comparison of hydroxyl radical generation in patients
undergoing coronary artery bypass grafting with and without cardiopulmonary
bypass. Free Radic Res 2006; 40(2):127-133.
(11) Schnickel GT, Ross DJ, Beygui R, Shefizadeh A, Laks H, Saggar R et
al. Modified reperfusion in clinical lung transplantation:
the results of 100 consecutive cases. J Thorac Cardiovasc Surg 2006;
131(1):218-223.
(12) Ustunsoy H, Sivrikoz MC, Tarakcioglu M, Bakir K, Guldur E, Celkan
MA. The effects of pentoxifylline on the myocardial
inflammation and ischemia-reperfusion injury during cardiopulmonary bypass.
J Card Surg 2006; 21(1):57-61.
(13) Whitaker DC, Stygall J, Harrison MJ, Mackie IJ, Kemp M, Hooper J et
al. Leucocyte-depleting arterial line filtration does not
reduce myocardial injury assessed by Troponin T during routine coronary artery
bypass grafting using crossclamp fibrillation. Perfusion 2006;
21(1):55-60.
(2) Guillen RV, Briones FR, Marin PM, Jover AS, Represa JM, Colom AP.
Lung Graft Dysfunction in the Early Postoperative Period After Lung and Heart
Lung Transplantation. Transplant Proc 2005; 37(9):3994-3995.
(3) Hoedemaekers CW, Pickkers P, Netea MG, van Deuren M, Van der Hoeven
JG. Intensive insulin therapy does not alter the inflammatory response in
patients undergoing coronary artery bypass grafting: a randomized controlled
trial [ISRCTN95608630]. Crit Care 2005; 9(6):R790-R797.
(4) Koskenkari J, Rimpilainen J, Biancari F, Surcel HM, Kaukoranta P,
Kiviluoma K et al. Leukocyte depleting filter attenuates myocardial injury
during elective coronary artery bypass surgery. Scand Cardiovasc J 2005;
39(6):358-368.
(5) Alexiou C, Sheppard S, Smith D, Gibbs R, Haw MP. Effect of Blood
Temperature on the Efficacy of Systemic Leucodepletion during Cardiopulmonary
Bypass: A Prospective Randomized Clinical Study. ASAIO J 2005; 51(6):802-807.
(6) Arkader R, Troster EJ, Lopes MR, Junior RR, Carcillo J, Leoni C et
al. Procalcitonin does discriminate between sepsis and systemic inflammatory
response syndrome. Arch Dis Child 2005; .
(7) Nollert G, Schwabenland I, Maktav D, Kur F, Christ F, Fraunberger P
et al. Miniaturized cardiopulmonary bypass in coronary artery bypass surgery:
marginal impact on inflammation and coagulation but loss of safety margins. Ann
Thorac Surg 2005; 80(6):2326-2332.
(8) Raja SG, Dreyfus GD. Modulation of systemic inflammatory response
after cardiac surgery. Asian Cardiovasc Thorac Ann 2005; 13(4):382-395.
(9) Pawar M, Mehta Y, Ansari A, Nair R, Trehan N. Nosocomial infections
and balloon counterpulsation: risk factors and outcome. Asian Cardiovasc Thorac
Ann 2005; 13(4):316-320.
(10) Fayaz KM, Pugh S, Balachandran S, Sudheer PS, Hall JE. Histamine
release during adult cardiopulmonary bypass. Anaesthesia 2005; 60(12):1179-1184.
(11) Tomic V, Russwurm S, Moller E, Claus RA, Blaess M, Brunkhorst F et
al. Transcriptomic and proteomic patterns of systemic inflammation in on-pump
and off-pump coronary artery bypass grafting. Circulation 2005;
112(19):2912-2920.
(12) Walker T, Wendel HP, Tetzloff L, Heidenreich O, Ziemer G.
Suppression of ICAM-1 in human venous endothelial cells by small interfering
RNAs. Eur J Cardiothorac Surg 2005; 28(6):816-820.
(13) Chello M, Goffredo C, Patti G, Candura D, Melfi R, Mastrobuoni S et
al. Effects of atorvastatin on arterial endothelial function in coronary bypass
surgery. Eur J Cardiothorac Surg 2005; 28(6):805-810.
(14) Ando M, Park IS, Wada N, Takahashi Y. Steroid supplementation: a
legitimate pharmacotherapy after neonatal open heart surgery. Ann Thorac Surg
2005; 80(5):1672-1678.
(15) Morariu AM, Loef BG, Aarts LP, Rietman GW, Rakhorst G, van Oeveren W
et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump
coronary artery bypass grafting: a study on myocardial, pulmonary, renal,
intestinal, and hepatic injury. Chest 2005; 128(4):2677-2687.
(16) Perrault LP, Carrier M. The central role of the endothelium in graft
coronary vasculopathy and heart transplantation. Can J Cardiol 2005;
21(12):1077-1083.
(17) Elmistekawy EM. Evaluation of surgical trauma and cardiopulmonary
bypass as factors in inflammatory status after cardiac surgery. J Thorac
Cardiovasc Surg 2005; 130(4):1226-1227.
(2) Chen Z, Chen H, Rhee P, Koustova E, Ayuste EC, Honma K et al. Induction
of profound hypothermia modulates the immune/inflammatory response in a swine
model of lethal hemorrhage. Resuscitation 2005; 66(2):209-216.
(3) Clark JA, Bar-Yosef S, Anderson A, Newman MF, Landolfo K, Grocott HP.
Postoperative hyperthermia following off-pump versus on-pump coronary artery
bypass surgery. J Cardiothorac Vasc Anesth 2005; 19(4):426-429.
(4) Fontes ML, Mathew JP, Rinder HM, Zelterman D, Smith BR, Rinder CS. Atrial
fibrillation after cardiac surgery/cardiopulmonary bypass is associated with
monocyte activation. Anesth Analg 2005; 101(1):17-23, table.
(5) Franke A, Lante W, Fackeldey V, Becker HP, Kurig E, Zoller LG et al. Pro-inflammatory
cytokines after different kinds of cardio-thoracic surgical procedures: is what
we see what we know? Eur J Cardiothorac Surg 2005; .
(6) Gessler P, Pretre R, Burki C, Rousson V, Frey B, Nadal D. Monocyte
function-associated antigen expression during and after pediatric cardiac
surgery. J Thorac Cardiovasc Surg 2005; 130(1):54-60.
(7) Gillespie EL, Gryskiewicz KA, White CM, Kluger J, Humphrey C, Horowitz S et
al. Effect of aprotinin on the frequency of postoperative atrial fibrillation
or flutter. Am J Health Syst Pharm 2005; 62(13):1370-1374.
(8) Graziani G, Szabo C. Clinical perspectives of PARP inhibitors.
Pharmacol Res 2005; 52(1):109-118.
(9) Hattori T, Khan MM, Colman RW, Edmunds LH, Jr. Plasma tissue factor plus
activated peripheral mononuclear cells activate factors VII and X in cardiac
surgical wounds. J Am Coll Cardiol 2005; 46(4):707-713.
(10) Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH et al.
Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized
controlled pilot study of left atrial appendage occlusion during coronary bypass
surgery in patients at risk for stroke. Am Heart J 2005; 150(2):288-293.
(11) Karamlou T, Schultz JM, Silliman C, Sandquist C, You J, Shen I et al.
Using a miniaturized circuit and an asanguineous prime to reduce neutrophil-mediated
organ dysfunction following infant cardiopulmonary bypass. Ann Thorac Surg
2005; 80(1):6-13.
(12) Keenan TD, Abu-Omar Y, Taggart DP. Bypassing the pump: changing
practices in coronary artery surgery. Chest 2005; 128(1):363-369.
(13) Lamarche Y, Malo O, Thorin E, Denault A, Carrier M, Roy J et al. Inhaled
but not intravenous milrinone prevents pulmonary endothelial dysfunction after
cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 130(1):83-92.
(14) Malagon I, Onkenhout W, Klok M, Linthorst L, van der Poel PF, Bovill JG et
al. Dexamethasone reduces gut permeability in pediatric cardiac surgery.
J Thorac Cardiovasc Surg 2005; 130(2):265-271.
(15) Matsuzaki K, Hiramatsu Y, Homma S, Sato S, Shigeta O, Sakakibara Y.
Sivelestat reduces inflammatory mediators and preserves neutrophil deformability
during simulated extracorporeal circulation. Ann Thorac Surg 2005;
80(2):611-617.
(16) Pai KR, Ramnarine IR, Grayson AD, Mediratta NK. The effect of chronic
steroid therapy on outcomes following cardiac surgery: a propensity-matched
analysis. Eur J Cardiothorac Surg 2005; 28(1):138-142.
(17) Paparella D, Al Radi OO, Meng QH, Venner T, Teoh K, Young E. The effects
of high-dose heparin on inflammatory and coagulation parameters following
cardiopulmonary bypass. Blood Coagul Fibrinolysis 2005; 16(5):323-328.
(18) Perez A, Ito H, Farivar RS, Cohn LH, Byrne JG, Rawn JD et al. Risk
factors and outcomes of pancreatitis after open heart surgery. Am J Surg
2005; 190(3):401-405.
(19) Podgoreanu MV, Michelotti GA, Sato Y, Smith MP, Lin S, Morris RW et al.
Differential cardiac gene expression during cardiopulmonary bypass: ischemia-independent
upregulation of proinflammatory genes. J Thorac Cardiovasc Surg 2005;
130(2):330-339.
(20) Sato Y, Hiramatsu Y, Homma S, Sato M, Sato S, Endo S et al.
Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes
during extracorporeal circulation. J Thorac Cardiovasc Surg 2005;
130(2):346-350.
(21) Smith SL, Heal DJ, Martin KF. KTX 0101: A Potential Metabolic Approach
to Cytoprotection in Major Surgery and Neurological Disorders. CNS Drug Rev
2005; 11(2):113-140.
(22) Sreeram GM, Welsby IJ, Sharma AD, Phillips-Bute B, Smith PK, Slaughter TF.
Infectious complications after cardiac surgery: lack of association with
fresh frozen plasma or platelet transfusions. J Cardiothorac Vasc Anesth
2005; 19(4):430-434.
(23) Szabo C. Pharmacological inhibition of poly(ADP-ribose) polymerase in
cardiovascular disorders: future directions. Curr Vasc Pharmacol 2005;
3(3):301-303.
(24) Weiss M, Dullenkopf A, Hasenclever P. Performance of automated air
tonometry under hypothermia. Anaesthesia 2005; 60(7):705-707.
(25) Wippermann J, Albes JM, Hartrumpf M, Kaluza M, Vollandt R, Bruhin R et al.
Comparison of minimally invasive closed circuit extracorporeal circulation
with conventional cardiopulmonary bypass and with off-pump technique in CABG
patients: selected parameters of coagulation and inflammatory system. Eur J
Cardiothorac Surg 2005; 28(1):127-132.
(26) Wrigge H, Uhlig U, Baumgarten G, Menzenbach J, Zinserling J, Ernst M et al.
Mechanical ventilation strategies and inflammatory responses to cardiac
surgery: a prospective randomized clinical trial. Intensive Care Med 2005; .
(27) Yeager MP, Rassias AJ, Fillinger MP, Discipio AW, Gloor KE, Gregory JA et
al. Cortisol antiinflammatory effects are maximal at postoperative plasma
concentrations. Crit Care Med 2005; 33(7):1507-1512.
(28) Zhang S, Wang S, Li Q, Yao S, Zeng B, Ziegelstein RC et al. Capillary
leak syndrome in children with C4A-deficiency undergoing cardiac surgery with
cardiopulmonary bypass: a double-blind, randomised controlled study. Lancet
2005; 366(9485):556-562.
(29) Zupancich E, Paparella D, Turani F, Munch C, Rossi A, Massaccesi S et al.
Mechanical ventilation affects inflammatory mediators in patients undergoing
cardiopulmonary bypass for cardiac surgery: a randomized clinical trial. J
Thorac Cardiovasc Surg 2005; 130(2):378-383.
(2) Wippermann J, Albes JM, Hartrumpf M, Kaluza M, Vollandt R, Bruhin R et al.
Comparison of minimally invasive closed circuit extracorporeal circulation
with conventional cardiopulmonary bypass and with off-pump technique in CABG
patients: selected parameters of coagulation and inflammatory system. Eur J
Cardiothorac Surg 2005; .
(3) de Vroege R, Huybregts R, van Oeveren W, van Klarenbosch J, Linley G, Mutlu
J et al. The impact of heparin-coated circuits on hemodynamics during and
after cardiopulmonary bypass. Artif Organs 2005; 29(6):490-497.
(4) Shander A, Rijhwani TS. Clinical Outcomes in Cardiac Surgery:
Conventional Surgery versus Bloodless Surgery. Anesthesiol Clin North
America 2005; 23(2):327-345.
(5) Lin TC, Li CY, Tsai CS, Ku CH, Wu CT, Wong CS et al. Neutrophil-mediated
secretion and activation of matrix metalloproteinase-9 during cardiac surgery
with cardiopulmonary bypass. Anesth Analg 2005; 100(6):1554-1560.
(6) Faber P, Ronald A, Millar BW. Methylthioninium chloride: pharmacology and
clinical applications with special emphasis on nitric oxide mediated
vasodilatory shock during cardiopulmonary bypass. Anaesthesia 2005;
60(6):575-587.
(7) Mielck F, Ziarkowski A, Hanekop G, Armstrong VW, Hilgers R, Weyland A et al.
Cerebral inflammatory response during and after cardiac surgery. Eur J
Anaesthesiol 2005; 22(5):347-352.
(8) Mangi AA, Christison-Lagay ER, Torchiana DF, Warshaw AL, Berger DL.
Gastrointestinal complications in patients undergoing heart operation: an
analysis of 8709 consecutive cardiac surgical patients. Ann Surg 2005;
241(6):895-901.
(9) Pavelkova M, Kubala L, Ciz M, Pavlik P, Wagner R, Slavik J et al. Blood
phagocyte activation during open heart surgery with cardiopulmonary bypass.
Physiol Res 2005; .
(10) Blacher C, Neumann J, Jung LA, Lucchese FA, Ribeiro JP. Off-pump
coronary artery bypass grafting does not reduce lymphocyte activation. Int J
Cardiol 2005; 101(3):473-479.
(11) Li C, Zhao W, Wu K, Zhang J, Jia N. CD11b may be a less satisfactory
indicator for cardiac ischemia-reperfusion injury in coronary artery bypass
graft surgery with cardiopulmonary bypass than cardiac troponin I. J Clin
Anesth 2005; 17(3):158-162.
(12) Williams EA, Ing RJ, Hart JP, Jaggers J, Kern FH, Craig DM et al.
Soluble alpha2-macroglobulin receptor is increased in endotracheal aspirates
from infants and children after cardiopulmonary bypass. J Thorac Cardiovasc
Surg 2005; 129(5):1098-1103.
(13) Christen S, Finckh B, Lykkesfeldt J, Gessler P, Frese-Schaper M, Nielsen P
et al. Oxidative stress precedes peak systemic inflammatory response in
pediatric patients undergoing cardiopulmonary bypass operation. Free Radic
Biol Med 2005; 38(10):1323-1332.
(14) Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein
is a risk indicator for atrial fibrillation after myocardial revascularization.
Ann Thorac Surg 2005; 79(5):1530-1535.
(15) Bingol H, Cingoz F, Balkan A, Kilic S, Bolcal C, Demirkilic U et al. The
effect of oral prednisolone with chronic obstructive pulmonary disease
undergoing coronary artery bypass surgery. J Card Surg 2005; 20(3):252-256.
(16) Bapat V, Allen D, Young C, Roxburgh J, Ibrahim M. Survival and quality
of life after cardiac surgery complicated by prolonged intensive care. J
Card Surg 2005; 20(3):212-217.
(17) Yeh CH, Chen TP, Wu YC, Lin YM, Jing LP. Inhibition of NFkappaB
activation with curcumin attenuates plasma inflammatory cytokines surge and
cardiomyocytic apoptosis following cardiac ischemia/reperfusion. J Surg Res
2005; 125(1):109-116.
(18) Melley DD, Evans TW, Quinlan GJ. Redox regulation of neutrophil
apoptosis and the systemic inflammatory response syndrome. Clin Sci (Lond)
2005; 108(5):413-424.
(19) Beghetti M, Black SM, Fineman JR. Endothelin-1 in congenital heart
disease. Pediatr Res 2005; 57(5 Pt 2):16R-20R.
(20) Sbrana S, Bevilacqua S, Buffa M, Spiller D, Parri MS, Gianetti J et al.
Post-reperfusion changes of monocyte function in coronary blood after
extracorporeal circulation. Cytometry B Clin Cytom 2005; 65(1):14-21.
(21) Andrasi TB, Blazovics A, Szabo G, Vahl CF, Hagl S. Poly(ADP-ribose)
polymerase inhibitor PJ-34 reduces mesenteric vascular injury induced by
experimental cardiopulmonary bypass with cardiac arrest. Am J Physiol Heart
Circ Physiol 2005; 288(6):H2972-H2978.
2. Bingol H, Cingoz F, Balkan A, Kilic S, Bolcal C, Demirkilic U, Tatar H:
The effect of oral prednisolone with chronic obstructive pulmonary disease
undergoing coronary artery bypass surgery. J.Card Surg. 2005; 20: 252-6
3. Yamaguchi A, Endo H, Kawahito K, Adachi H, Ino T: Off-pump coronary artery
bypass grafting attenuates proinflammatory markers.
Jpn.J.Thorac.Cardiovasc.Surg.2005; 53: 127-32
4. Ilmakunnas M, Pesonen EJ, Ahonen J, Ramo J, Siitonen S, Repo H: Activation
of neutrophils and monocytes by a leukocyte-depleting filter used throughout
cardiopulmonary bypass. Thorac.Cardiovasc.Surg. 2005; 129: 851-9
5. Prondzinsky R, Knupfer A, Loppnow H, Redling F, Lehmann DW, Stabenow I,
Witthaut R, Unverzagt S, Radke J, Zerkowski HR, Werdan K: Surgical trauma
affects the proinflammatory status after cardiac surgery to a higher degree than
cardiopulmonary bypass. J.Thorac.Cardiovasc.Surg. 2005; 129: 760-6
6. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi
K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated
lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.
Lancet 2005; 365: 1231-8
7. Hiramatsu Y, Homma S, Sato Y, Sato S, Matsuzaki K, Shigeta O, Sakakibara Y:
Nafamostat preserves neutrophil deformability and reduces microaggregate
formation during simulated extracorporeal circulation. Ann.Thorac.Surg.
2005; 79: 1326-32
8. Tirilomis T, Friedrich M, Sirbu H, Aleksic I, Busch T: Intraoperative
hemofiltration in adults: prevention of hypercirculatory syndrome? Asian
Cardiovasc.Thorac.Ann.2005; 13: 17-9
9. Murakami T, Iwagaki H, Saito S, Ohtani S, Kuroki K, Kuinose M, Tanaka N,
Tanemoto K: Equivalence of the acute cytokine surge and myocardial injury
after coronary artery bypass grafting with and without a novel extracorporeal
circulation system. J.Int.Med.Res. 2005; 33: 133-49
10. Sbrana S, Bevilacqua S, Buffa M, Spiller D, Parri MS, Gianetti J, De
Filippis R, Clerico A: Post-reperfusion changes of monocyte function in
coronary blood after extracorporeal circulation. Cytometry B Clin.Cytom.
2005; 65: 14-21
11. Ener S, Yilmaz M: The effect of single low-dose Methylprednisolone on the
cardiopulmonary bypass-induced inflammatory response.
Eur.J.Cardiothorac.Surg. 2005; 27: 729-30
12. Luyten CR, van Overveld FJ, De Backer LA, Sadowska AM, Rodrigus IE, De Hert
SG, De Backer WA: Antioxidant defence during cardiopulmonary bypass surgery.
Eur.J.Cardiothorac.Surg. 2005; 27: 611-6
13. Zimmermann N, Kurt M, Wenk A, Winter J, Gams E, Hohlfeld T: Is
cardiopulmonary bypass a reason for aspirin resistance after coronary artery
bypass grafting? Eur.J.Cardiothorac.Surg. 2005; 27: 606-10
14. Yeh CH, Lin YM, Wu YC, Lin PJ: Inhibition of NF-kappaB activation can
attenuate ischemia/reperfusion-induced contractility impairment via decreasing
cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase
expression. J.Cardiovasc.Pharmacol. 2005; 45: 301-9
15. Staton GW, Williams WH, Mahoney EM, Hu J, Chu H, Duke PG, Puskas JD:
Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a
randomized trial. Chest 2005; 127: 892-901
16. Charman A, Muriithi EW, Milne E, Wheatley DJ, Armstrong RA, Belcher PR:
Fish oil before cardiac surgery: neutrophil activation is unaffected but
myocardial damage is moderated. Prostaglandins Leukot.Essent.Fatty Acids
2005; 72: 257-65
17. Schippers EF, van ', V, van Voorden S, Martina CA, Huizinga TW, le Cessie S,
van Dissel JT: IL-10 and toll-like receptor-4 polymorphisms and the in vivo
and ex vivo response to endotoxin. Cytokine 2005; 29: 215-28
18. Duffy JY, Schwartz SM, Lyons JM, Bell JH, Wagner CJ, Zingarelli B, Pearl JM:
Calpain inhibition decreases endothelin-1 levels and pulmonary hypertension
after cardiopulmonary bypass with deep hypothermic circulatory arrest. Crit
Care Med.2005; 33: 623-8
19. Schuller AM, Windolf J, Blaheta R, Cinatl J, Kreuter J, Wimmer-Greinecker G,
Moritz A, Scholz M: Degradation of microvascular brain endothelial cell
beta-catenin after co-culture with activated neutrophils from patients
undergoing cardiac surgery with prolonged cardiopulmonary bypass.
Biochem.Biophys.Res.Commun. 2005; 329:616-23
20. Misawa Y: Markers of endothelial activation during cardiopulmonary bypass.Ann.Thorac.Surg.
2005; 79: 1096
21. Videm V: Markers of endothelial activation during cardiopulmonary bypass:
reply.Ann.Thorac.Surg. 2005; 79: 1096
22. Bull BS, Hay K, Razzouk AJ, Huse WM: Reinfusion of aspirated pericardial
blood during CPB. Part II. Laparotomy sponges are hazardous parts of the CPB
circuit? Blood Cells Mol.Dis. 2005; 34: 144-50
23. Bull BS, Hay K: Reinfusion of aspirated pericardial blood during CPB.
Part I. Hypothesis: laparotomy sponges are a significant part of the CPB
circuit? Blood Cells Mol.Dis. 2005; 34: 141-3
24. Andersson B, Nilsson J, Brandt J, Hoglund P, Andersson R:
Gastrointestinal complications after cardiac surgery. Br.J.Surg. 2005; 92:
326-33
(2) Bourbon A, Vionnet M, Leprince P, Vaissier E, Copeland J, McDonagh P et al.
The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced
systemic inflammatory response. Eur J Cardiothorac Surg 2004; 26(5):932-938.
(3) Bremer YA, Salloum F, Ockaili R, Chou E, Moskowitz WB, Kukreja RC.
Sildenafil citrate (viagra) induces cardioprotective effects after ischemia/reperfusion
injury in infant rabbits. Pediatr Res 2005; 57(1):22-27.
(4) Chello M, Carassiti M, Agro F, Mastroroberto P, Pugliese G, Colonna D et al.
Simvastatin blunts the increase of circulating adhesion molecules after
coronary artery bypass surgery with cardiopulmonary bypass. J Cardiothorac
Vasc Anesth 2004; 18(5):605-609.
(5) Chen JC, Rollins SA, Shernan SK, Boyce S, Allen K, Wallace A et al.
Pharmacologic c5-complement suppression reduces blood loss during on-pump
cardiac surgery. JCard Surg 2005; 20(1):35-41.
(6) Chukwuemeka AO, Brown KA, Venn GE, Chambers DJ. Changes in P-selectin
expression on cardiac microvessels in blood-perfused rat hearts subjected to
ischemiareperfusion. Ann Thorac Surg 2005; 79(1):204-211.
(7) de Vries AJ, Gu YJ, van Oeveren W. Leucocyte filtration of residual
heart-lung machine blood in children undergoing congenital heart surgery.
Perfusion 2004; 19(6):345-349.
(8) Devbhandari MP, Balasubramanian SK, Codispoti M, Nzewi OC, Prasad SU.
Preoperative angiotensin-converting enzyme inhibition can cause severe post
CPBvasodilation--current UK opinion. Asian Cardiovasc Thorac Ann 2004;
12(4):346-349.
(9) Fedak PW, Rao V, Verma S, Ramzy D, Tumiati L, Miriuka S et al. Combined
endothelial and myocardial protection by endothelin antagonism enhances
transplant allograft preservation. J Thorac Cardiovasc Surg 2005;
129(2):407-415.
(10) Gessler P, Pretre R, Hohl V, Rousson V, Fischer J, Dahinden C.
CXC-chemokine stimulation of neutrophils correlates with plasma levels of
myeloperoxidase and lactoferrin and contributes to clinical outcome after
pediatric cardiac surgery. Shock
2004; 22(6):513-520.
(11) Gessler P, Hohl V, Carrel T, Pfenninger J, Schmid ER, Baenziger O et al.Administration
of Steroids in Pediatric Cardiac Surgery: Impact on Clinical Outcome and
Systemic Inflammatory Response. Pediatr Cardiol 2005; .
(12) Jarvinen O, Saarinen T, Julkunen J, Laurikka J, Huhtala H, Tarkka MR.
Improved health-related quality of life after coronary artery bypass grafting is
unrelated to use of cardiopulmonary bypass. World J Surg 2004;
28(10):1030-1035.
(13) Keshavjee S, Davis RD, Zamora MR, de Perrot M, Patterson GA. A
randomized, placebo-controlled trial of complement inhibition in
ischemia-reperfusion injury after lung transplantation in human beings. J
Thorac Cardiovasc Surg 2005; 129(2):423-428.
(14) Lalu MM, Pasini E, Schulze CJ, Ferrari-Vivaldi M, Ferrari-Vivaldi G,
Bachetti T et al. Ischaemia-reperfusion injury activates matrix
metalloproteinases in the human heart. Eur Heart J 2005; 26(1):27-35.
(15) Lante W, Franke A, Weinhold C, Markewitz A. Immunoglobulin levels and
lymphocyte subsets following cardiac operations: further evidence for a T-helper
cell shifting*. Thorac Cardiovasc Surg 2005; 53(1):16-22.
(16) Mendonca-Filho HT, Gomes RV, Almeida Campos LA, Tura B, Nunes EM, Gomes R
et al. Circulating levels of macrophage migration inhibitory factor are
associated with mild pulmonary dysfunction after cardiopulmonary bypass.
Shock 2004; 22(6):533-537.
(17) Murphy GJ, Angelini GD. Side effects of cardiopulmonary bypass: what is
the reality? J Card Surg 2004; 19(6):481-488.
(18) Newland RF, Baker RA, Mazzone AL, Ottens J, Sanderson AJ, Moubarak JR.
Removal of glucose from the cardiopulmonary bypass prime: a prospective clinical
audit. J Extra Corpor Technol 2004; 36(3):240-244.
(19) Oda K, Hata M, Kawatsu S, Adachi O, Yamaya K, Saiki Y et al. Quality of
life in elderly patients following thoracic aortic surgery. Jpn J Thorac
Cardiovasc Surg 2004;52(11):515-523.
(20) Pandey R, Grayson AD, Pullan DM, Fabri BM, Dihmis WC. Total arterial
revascularisation: effect of avoiding cardiopulmonary bypass on in-hospital
mortality and morbidity in a propensity-matched cohort. Eur J Cardiothorac
Surg 2005;27(1):94-98.
(21) Plumpton K, Haas NA. Identifying infants at risk of marked thyroid
suppression postcardiopulmonary bypass. Intensive Care Med 2005; .
(22) Rubens FD, Nathan H, Labow R, Williams KS, Wozny D, Karsh J et al.
Effects of methylprednisolone and a biocompatible copolymer circuit on blood
activation during cardiopulmonary bypass. Ann Thorac Surg 2005;
79(2):655-665.
(23) Smigla GR, Lawson DS, Shearer IR, Jaggers J, Milano C, Welsby I. An
ultrafiltration technique for directly reinfusing residual cardiopulmonary
bypass blood. J ExtraCorpor Technol 2004; 36(3):231-234.
(24) Tornberg DC, Angdin M, Settergen G, Liska J, Lundberg JO, Weitzberg E.
Exhaled nitric oxide before and after cardiac surgery with cardiopulmonary
bypass--response to acetylcholine and nitroglycerin. Br J Anaesth 2005;
94(2):174-180.
(25) Turker H, Donmez A, Zeyneloglu P, Sezgin A, Ulucam M. Effects of
enalaprilat infusion on hemodynamics and renal function in patients undergoing
cardiac surgery. Anadolu Kardiyol Derg 2004; 4(4):296-300.
(26) van den GJ, Nieuwland R, van den BA, van Oeveren W, Rutten P, Tijssen J et
al. Reduced complement activation during cardiopulmonary bypass does not
affect the postoperative acute phase response. Eur J Cardiothorac Surg 2004;
26(5):926-931.
(27) Vermes E, Demaria RG, Martineau R, Cartier R, Pellerin M, Hebert Y et al.
Increased early postoperative morbidity with off-pump coronary artery bypass
grafting surgeryin patients with diabetes. Can J Cardiol 2004;
20(14):1461-1465.